- Home
- IOVA vs TASK Comparison
IOVA vs TASK Comparison
Compare IOVA & TASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IOVA | TASK |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.6M | 1.1B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IOVA | TASK |
|---|---|---|
| Price | $2.22 | $12.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 5 |
| Target Price | $10.36 | ★ $17.20 |
| AVG Volume (30 Days) | ★ 16.6M | 362.7K |
| Earning Date | 11-06-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.76 |
| EPS | N/A | ★ 0.88 |
| Revenue | $250,425,000.00 | ★ $1,144,833,000.00 |
| Revenue This Year | $60.94 | $20.00 |
| Revenue Next Year | $60.85 | $11.47 |
| P/E Ratio | ★ N/A | $13.81 |
| Revenue Growth | ★ 175.62 | 19.88 |
| 52 Week Low | $1.64 | $10.68 |
| 52 Week High | $9.30 | $18.60 |
Technical Indicators
Market Signals| Indicator | IOVA | TASK |
|---|---|---|
| Relative Strength Index (RSI) | 47.43 | 48.67 |
| Support Level | $2.13 | $11.45 |
| Resistance Level | $2.55 | $11.73 |
| Average True Range (ATR) | 0.16 | 0.35 |
| MACD | -0.03 | 0.23 |
| Stochastic Oscillator | 25.57 | 98.66 |
Price Performance
Historical ComparisonAbout IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About TASK TaskUs Inc.
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world-wide Game-changing companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.